This is a news story, published by NBC News, that relates primarily to Neffy news.
For more Neffy news, you can click here:
more Neffy newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from NBC News, you can click here:
more news from NBC NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
dose nasal spray. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest epinephrine injection products news, anaphylaxis news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
nasal sprayNBC News
•
83% Informative
The spray, which will be sold under the brand name Neffy , is seen as an alternative to EpiPen and other autoinjectors like Kaleo ’s Auvi-Q.
Last year , the FDA declined to approve the spray and requested additional testing, in a decision that went against the recommendation from independent experts.
VR Score
83
Informative language
82
Neutral language
82
Article tone
formal
Language
English
Language complexity
78
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links